Masaru Matsuda sold $250K of Arcutis Biotherapeutics, Inc. (ARQT) stock

Masaru Matsuda sold 9,989 shares of ARQT stock worth $250K, per an SEC Form 4 filed Sep 10, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 8, 2026, 2 days before it was made public.

ARQT has moved +6.4% since the trade date, from $24.39 to $25.96 (Sep 21, 2026 close).